168 related articles for article (PubMed ID: 9863136)
1. Huperzine A (shuangyiping): a promising drug for Alzheimer's disease.
Tang XC
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):481-4. PubMed ID: 9863136
[TBL] [Abstract][Full Text] [Related]
2. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
Wang R; Yan H; Tang XC
Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
Wang R; Tang XC
Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
[TBL] [Abstract][Full Text] [Related]
5. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
Ha GT; Wong RK; Zhang Y
Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
[TBL] [Abstract][Full Text] [Related]
6. Role of huperzine a in the treatment of Alzheimer's disease.
Desilets AR; Gickas JJ; Dunican KC
Ann Pharmacother; 2009 Mar; 43(3):514-8. PubMed ID: 19240260
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
Bores GM; Huger FP; Petko W; Mutlib AE; Camacho F; Rush DK; Selk DE; Wolf V; Kosley RW; Davis L; Vargas HM
J Pharmacol Exp Ther; 1996 May; 277(2):728-38. PubMed ID: 8627552
[TBL] [Abstract][Full Text] [Related]
8. Huperzine A from Huperzia species--an ethnopharmacolgical review.
Ma X; Tan C; Zhu D; Gang DR; Xiao P
J Ethnopharmacol; 2007 Aug; 113(1):15-34. PubMed ID: 17644292
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
Zhang HY; Tang XC
Trends Pharmacol Sci; 2006 Dec; 27(12):619-25. PubMed ID: 17056129
[TBL] [Abstract][Full Text] [Related]
10. Huperzia quadrifariata and Huperzia reflexa alkaloids inhibit acetylcholinesterase activity in vivo in mice brain.
Konrath EL; Neves BM; Passos Cdos S; Lunardi PS; Ortega MG; Cabrera JL; Gonçalves CA; Henriques AT
Phytomedicine; 2012 Nov; 19(14):1321-4. PubMed ID: 23022390
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
[TBL] [Abstract][Full Text] [Related]
12. Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.
Patocka J
Acta Medica (Hradec Kralove); 1998; 41(4):155-7. PubMed ID: 9951045
[TBL] [Abstract][Full Text] [Related]
13. [Facilitation of cholinergic transmission by huperzine A in toad paravertebral ganglia in vitro].
Zhang GB; Wang MY; Zheng JQ; Tang XC
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):158-61. PubMed ID: 8010112
[TBL] [Abstract][Full Text] [Related]
14. Anticholinesterase activity and identification of huperzine A in three Mexican lycopods: Huperzia cuernavacensis, Huperzia dichotoma and Huperzia linifolia (Lycopodiaceae).
García MV; Poser GLV; Apel M; Tlatilpa RC; Mendoza-Ruiz A; Villarreal ML; Henriques AT; Taketa AC
Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):235-239. PubMed ID: 28625948
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
16. [Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential].
Pilotaz F; Masson P
Ann Pharm Fr; 1999 Sep; 57(5):363-73. PubMed ID: 10520506
[TBL] [Abstract][Full Text] [Related]
17. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.
Bai DL; Tang XC; He XC
Curr Med Chem; 2000 Mar; 7(3):355-74. PubMed ID: 10637369
[TBL] [Abstract][Full Text] [Related]
18. An update on huperzine A as a treatment for Alzheimer's disease.
Little JT; Walsh S; Aisen PS
Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
[TBL] [Abstract][Full Text] [Related]
19. Effects of a memory enhancing peptide on cognitive abilities of brain-lesioned mice: additivity with huperzine A and relative potency to tacrine.
Xu Z; Zheng H; Law SL; Dong So D; Han Y; Xue H
J Pept Sci; 2006 Jan; 12(1):72-8. PubMed ID: 15942937
[TBL] [Abstract][Full Text] [Related]
20. Effects of synthetic (-)-huperzine A on cholinesterase activities and mouse water maze performance.
Liu J; Zhang HY; Tang XC; Wang B; He XC; Bai DL
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):413-6. PubMed ID: 10375798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
